Get started
Author

Seiji Niho

Improved preparation of Abraxane ® I.V. Infusion (paclitaxel nanoparticles)
2026 · Tomoaki Toyama, Hironori Betsunoh, et al. · Journal of Oncology Pharmacy Practice · 1
Impact of vulnerability on concurrent chemoradiotherapy outcomes in patients with locally advanced non-small cell lung cancer using an integrated clinical trial database
2026 · Kenji Morimoto, Tadaaki Yamada, et al. · Therapeutic Advances in Medical Oncology · 1
Five-year overall survival in JCOG1205/1206: irinotecan or etoposide plus cisplatin for resected high-grade neuroendocrine carcinoma of the lung
2026 · Hirotsugu Kenmotsu, Seiji Niho, et al. · Lung Cancer
A Case of IgG4 ‐Related Disease That Mimics an Anterior Mediastinal Malignant Tumour
2026 · Noriaki Nishimura, Yusuke Nakamura, et al. · Respirology Case Reports
PDF
EP.13.14 Real-World Data Analysis of Treatment Pattern and Prognosis of Patients With Limited-Stage Small Cell Lung Cancer in Japan
2025 · S. Niho, T. Kozuka, et al. · Journal of Thoracic Oncology
211P: Five-year survival outcomes from PIT-2: S-1 plus cisplatin with concurrent radiotherapy followed by surgery in stage IIIA (N2) lung squamous cell carcinoma
2025 · K. Takamochi, M. Tsuboi, et al. · Journal of Thoracic Oncology
PDF
EP08.02-159 Post Hoc Analyses of Dacomitinib-Associated Skin Disorders and Efficacy in the ARCHER 1050 Study
2022 · J. Li, X. Pu, et al. · Journal of Thoracic Oncology
PDF
1015P Phase III study of ramucirumab plus docetaxel versus atezolizumab for PD-L1 negative or weakly positive advanced non-small cell lung cancer after disease progression on platinum-based therapy: WJOG10317L study (EMERALD)
2022 · Y. Zenke, S. Niho, et al. · Annals of Oncology
Works count: 8
Citation count: 2
H-index: 1
I10-index:
Year
Topic
Type